Investor Relations



We are a leading science and technology company that delivers life-transforming medicines for serious diseases.

Founded by physician-scientists more than 30 years ago, our science-driven approach has resulted in seven FDA-approved medicines and numerous product candidates in a range of diseases, including cancer, asthma, pain and infectious diseases.

In addition to our medicines, our innovations include the VelociSuite® technologies, world-class manufacturing operations, one of the largest human sequencing efforts in the world and rapid response technologies being used for global good.




  • Feb 12

    Regeneron Announces Upcoming Investor Conference Presentations
  • Feb 08

    EYLEA® (aflibercept) Injection Reduced Risk of Developing Vision-Threatening Events by 75% After Two Years in Patients with Diabetic Retinopathy


  • Barclays Global Healthcare Conference
    Mar 10
    4:50 PM EDT
    Mar 10, 2020 | 4:50 PM EDT

  • Cowen 40th Annual Healthcare Conference
    Mar 2
    1:30 PM EST
    Mar 2, 2020 | 1:30 PM EST

  • SVB Leerink 9th Annual Global Healthcare Conference
    Feb 25
    10:00 AM EST
    Feb 25, 2020 | 10:00 AM EST